Skip to content
conflictLOW2026-05-06 22:12 UTC

Chemours expects Q2 adjusted EBITDA of $220M-$250M as it targets net leverage below 3.8x by year-end 2026

ORIGINAL SOURCE →via Seeking Alpha
ADVERTISEMENT
⚡ STAY AHEAD

Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.

GET THE SUNDAY BRIEFING →

RELATED · conflict